PITRM1 interaction studies with amyloidogenic nonapeptide mutants of familial Alzheimer’s disease

References

• Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics (Oxford, England), 22(2), 195–201. https://doi.org/10.1093/bioinformatics/bti770
   PubMed Web of Science ®Google Scholar
• Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., & Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research, 42(Web Server issue), W252–W258. https://doi.org/10.1093/nar/gku340
   PubMed Web of Science ®Google Scholar
• Bora, R. P., & Prabhakar, R. (2010). Elucidation of interactions of Alzheimer amyloid β Peptides (Aβ40 and Aβ42) with insulin degrading enzyme: A molecular dynamics study. Biochemistry, 49(18), 3947–3956. https://doi.org/10.1021/bi1002103
   PubMed Web of Science ®Google Scholar
• Bugiani, O., Giaccone, G., Rossi, G., Mangieri, M., Capobianco, R., Morbin, M., Mazzoleni, G., Cupidi, C., Marcon, G., Giovagnoli, A., Bizzi, A., Di Fede, G., Puoti, G., Carella, F., Salmaggi, A., Romorini, A., Patruno, G. M., Magoni, M., Padovani, A., & Tagliavini, F. (2010). Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Archives of Neurology, 67(8), 987–995. https://doi.org/10.1001/archneurol.2010.178
   PubMedGoogle Scholar
• Cha, M. Y., Han, S. H., Son, S. M., Hong, H. S., Choi, Y. J., Byun, J., & Mook-Jung, I. (2012). Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One, 7(4), e34929. https://doi.org/10.1371/journal.pone.0034929
   PubMed Web of Science ®Google Scholar
• Chen, J. X., & Yan, S. S. (2010). Role of mitochondrial amyloid-β in Alzheimer’s disease. Journal of Alzheimer's Disease, 20(s2), S569–S578. https://doi.org/10.3233/JAD-2010-100357
   PubMedGoogle Scholar
• Chen, W.-T., Hong, C.-J., Lin, Y.-T., Chang, W.-H., Huang, H.-T., Liao, J.-Y., Chang, Y.-J., Hsieh, Y.-F., Cheng, C.-Y., Liu, H.-C., Chen, Y.-R., & Cheng, I. H. (2012). Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies. PLoS One, 7(4), e35807. https://doi.org/10.1371/journal.pone.0035807
   PubMed Web of Science ®Google Scholar
• Chong, S.-H., Yim, J., & Ham, S. (2013). Structural heterogeneity in familial Alzheimer’s disease mutants of amyloid-beta peptides. Molecular bioSystems, 9(5), 997–1003. https://doi.org/10.1039/c2mb25457c
   PubMedGoogle Scholar
• Chow, K. M., Gakh, O., Payne, I. C., Juliano, M. A., Juliano, L., Isaya, G., & Hersh, L. B. (2009). Mammalian Pitrilysin: Substrate specificity and mitochondrial targeting. Biochemistry, 48(13), 2868–2877. https://doi.org/10.1021/bi8016125
   PubMed Web of Science ®Google Scholar
• Falkevall, A., Alikhani, N., Bhushan, S., Pavlov, P. F., Busch, K., Johnson, K. A., Eneqvist, T., Tjernberg, L., Ankarcrona, M., & Glaser, E. (2006). Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. The Journal of Biological Chemistry, 281(39), 29096–29104. https://doi.org/10.1074/jbc.M602532200
   PubMed Web of Science ®Google Scholar
• Fernandez-Madrid, I., Levy, E., Marder, K., & Frangione, B. (1991). Codon 618 variant of Alzheimer amyloid gene associated with inherited cerebral hemorrhage. Annals of Neurology, 30(5), 730–733. https://doi.org/10.1002/ana.410300516
   PubMed Web of Science ®Google Scholar
• Gessel, M. M., Bernstein, S., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012). Familial Alzheimer’s disease mutations differentially alter amyloid β-protein oligomerization. ACS Chemical Neuroscience, 3(11), 909–918. https://doi.org/10.1021/cn300050d
   PubMed Web of Science ®Google Scholar
• Grabowski, T. J., Cho, H. S., Vonsattel, J. P., Rebeck, G. W., & Greenberg, S. M. (2001). Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Annals of Neurology, 49(6), 697–705. http://www.ncbi.nlm.nih.gov/pubmed/11409420 https://doi.org/10.1002/ana.1009
   PubMed Web of Science ®Google Scholar
• Guo, Q., Manolopoulou, M., Bian, Y., Schilling, A. B., & Tang, W.-J. (2010). Molecular basis for the recognition and cleavages of IGF-II, TGF-α, and amylin by human insulin-degrading enzyme. Journal of Molecular Biology, 395(2), 430–443. https://doi.org/10.1016/j.jmb.2009.10.072
   PubMed Web of Science ®Google Scholar
• Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., & Ankarcrona, M. (2008). The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proceedings of the National Academy of Sciences of the United States of America, 105(35), 13145–13150. https://doi.org/10.1073/pnas.0806192105
   PubMed Web of Science ®Google Scholar
• Hatami, A., Monjazeb, S., Milton, S., & Glabe, C. G. (2017). Familial Alzheimer’s disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-β peptide. The Journal of Biological Chemistry, 292(8), 3172–3185. https://doi.org/10.1074/jbc.M116.755264
   PubMed Web of Science ®Google Scholar
• Hendriks, L., vanDuijn, C. M., Cras, P., Cruts, M., Vanhul, W., Vanharskamp, F., Warren, A., Mcinnis, M. G., Antonarakis, S. E., Martin, J. J., Hofman, A., & Vanbroeckhoven, C. (1992). Presenile-dementia and cerebral-hemorrhage linked to a mutation at codon-692 of the beta-amyloid precursor protein gene. Nature Genetics, 1(3), 218–221. https://doi.org/10.1038/ng0692-218
   PubMed Web of Science ®Google Scholar
• Janssen, J. C., Beck, J. A., Campbell, T. A., Dickinson, A., Fox, N. C., Harvey, R. J., Houlden, H., Rossor, M. N., & Collinge, J. (2003). Early onset familial Alzheimer’s disease: Mutation frequency in 31 families. Neurology, 60(2), 235–239. https://doi.org/10.1212/01.WNL.0000042088.22694.E3
   PubMed Web of Science ®Google Scholar
• Kaplan, W., & Littlejohn, T. G. (2001). Swiss-PDB viewer (deep view). Briefings in Bioinformatics, 2(2), 195–197. https://doi.org/10.1093/bib/2.2.195
   PubMedGoogle Scholar
• Kim, M., Hersh, L. B., Leissring, M. A., Ingelsson, M., Matsui, T., Farris, W., Lu, A., Hyman, B. T., Selkoe, D. J., Bertram, L., & Tanzi, R. E. (2007). Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. The Journal of Biological Chemistry, 282(11), 7825–7832. https://doi.org/10.1074/jbc.M609168200
   PubMed Web of Science ®Google Scholar
• Kim, W., & Hecht, M. H. (2008). Mutations enhance the aggregation propensity of the Alzheimer’s Aβ peptide. Journal of Molecular Biology, 377(2), 565–574. https://doi.org/10.1016/j.jmb.2007.12.079
   PubMed Web of Science ®Google Scholar
• King, J. V., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W.-J. (2014). Molecular basis of substrate recognition and degradation by human presequence protease. Structure (London, England : 1993), 22(7), 996–1007. https://doi.org/10.1016/j.str.2014.05.003
   PubMed Web of Science ®Google Scholar
• Kumar, S., Kumar Bhardwaj, V., Singh, R., & Purohit, R. (2021). Explicit-solvent molecular dynamics simulations revealed conformational regain and aggregation inhibition of I113T SOD1 by Himalayan bioactive molecules. Journal of Molecular Liquids, 339, 116798. https://doi.org/10.1016/j.molliq.2021.116798
   Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A, Open Source Drug Discovery Consortium. (2014). g _ mmpbsa - A GROMACS tool for MM-PBSA and its optimization for high-throughput binding energy calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• LaFerla, F. M., Green, K. N., & Oddo, S. (2007). Intracellular amyloid-β in Alzheimer’s disease. Nature Reviews. Neuroscience, 8(7), 499–509. https://doi.org/10.1038/nrn2168
   PubMed Web of Science ®Google Scholar
• Lai, R., Tang, W.-J., & Li, H. (2018). Catalytic mechanism of amyloid-β peptide degradation by insulin degrading enzyme: insights from quantum mechanics and molecular mechanics style Møller–Plesset second order perturbation theory calculation. Journal of Chemical Information and Modeling, 58(9), 1926–1934. https://doi.org/10.1021/acs.jcim.8b00406
   PubMed Web of Science ®Google Scholar
• Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T., Luyendijk, W., & Frangione, B. (1990). Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (New York, NY), 248(4959), 1124–1126. http://www.ncbi.nlm.nih.gov/pubmed/2111584 https://doi.org/10.1126/science.2111584
   Google Scholar
• Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H. (2004). ABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s disease. Science (New York, NY), 304(5669), 448–452. https://doi.org/10.1126/science.1091230
   Google Scholar
• Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006). Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: Implications for free radical generation and oxidative damage in disease progression. Human Molecular Genetics, 15(9), 1437–1449. https://doi.org/10.1093/hmg/ddl066
   PubMed Web of Science ®Google Scholar
• Manolopoulou, M., Guo, Q., Malito, E., Schilling, A. B., & Tang, W.-J. (2009). Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme. The Journal of Biological Chemistry, 284(21), 14177–14188. https://doi.org/10.1074/jbc.M900068200
   PubMed Web of Science ®Google Scholar
• Mashiach, E., Nussinov, R., & Wolfson, H. J. (2010). FiberDock: A web server for flexible induced-fit backbone refinement in molecular docking. Nucleic Acids Research, 38(Web Server), W457–W461. https://doi.org/10.1093/nar/gkq373
   PubMed Web of Science ®Google Scholar
• Masuda, Y., Nakanishi, A., Ohashi, R., Takegoshi, K., Shimizu, T., Shirasawa, T., & Irie, K. (2008). Verification of the intermolecular parallel beta-sheet in E22K-Abeta42 aggregates by solid-state NMR using rotational resonance: implications for the supramolecular arrangement of the toxic conformer of Abeta42. Bioscience, Biotechnology, and Biochemistry, 72(8), 2170–2175. https://doi.org/10.1271/bbb.80250
   PubMed Web of Science ®Google Scholar
• McCord, L. A., Liang, W. G., Dowdell, E., Kalas, V., Hoey, R. J., Koide, A., Koide, S., & Tang, W.-J. (2013). Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme. Proceedings of the National Academy of Sciences of the United States of America, 110(34), 13827–13832. https://doi.org/10.1073/pnas.1304575110
   PubMed Web of Science ®Google Scholar
• Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011). Aβ-degrading enzymes: Potential for treatment of Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 70(11), 944–959. https://doi.org/10.1097/NEN.0b013e3182345e46
   PubMed Web of Science ®Google Scholar
• Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., Näslund, J., & Lannfelt, L. (2001). The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nature Neuroscience, 4(9), 887–893. https://doi.org/10.1038/nn0901-887
   PubMed Web of Science ®Google Scholar
• Pagani, L., & Eckert, A. (2011). Amyloid-beta interaction with mitochondria. International Journal of Alzheimer's Disease, 2011, 925050–925012. https://doi.org/10.4061/2011/925050
   PubMedGoogle Scholar
• Pérez, A., Morelli, L., Cresto, J. C., & Castaño, E. M. (2000). Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochemical Research, 25(2), 247–255. https://doi.org/10.1023/a:1007527721160
   PubMed Web of Science ®Google Scholar
• Pinho, C. M., Teixeira, P. F., & Glaser, E. (2014). Mitochondrial import and degradation of amyloid-β peptide. Biochimica et Biophysica Acta, 1837(7), 1069–1074. https://doi.org/10.1016/j.bbabio.2014.02.007
   PubMed Web of Science ®Google Scholar
• Qin, W., & Jia, J. (2008). Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42. The European Journal of Neuroscience, 27(9), 2425–2432. https://doi.org/10.1111/j.1460-9568.2008.06207.x
   PubMed Web of Science ®Google Scholar
• Reddy, P. H. (2009). Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Experimental Neurology, 218(2), 286–292. https://doi.org/10.1016/j.expneurol.2009.03.042
   PubMed Web of Science ®Google Scholar
• Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–W447. https://doi.org/10.1093/nar/gkv315
   PubMed Web of Science ®Google Scholar
• Scheurer, M., Rodenkirch, P., Siggel, M., Bernardi, R. C., Schulten, K., Tajkhorshid, E., & Rudack, T. (2018). PyContact: Rapid, customizable, and visual analysis of noncovalent interactions in MD simulations. Biophysical Journal, 114(3), 577–583. https://doi.org/10.1016/j.bpj.2017.12.003
   PubMed Web of Science ®Google Scholar
• Serpell, L. C. (2000). Alzheimer’s amyloid fibrils: Structure and assembly. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1502(1), 16–30. https://doi.org/10.1016/S0925-4439(00)00029-6
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 1(1), a006189. https://doi.org/10.1101/cshperspect.a006189
   PubMed Web of Science ®Google Scholar
• Stahl, A., Moberg, P., Ytterberg, J., Panfilov, O., Brockenhuus Von Lowenhielm, H., Nilsson, F., & Glaser, E. (2002). Isolation and identification of a novel mitochondrial metalloprotease (PreP) that degrades targeting presequences in plants. The Journal of Biological Chemistry, 277(44), 41931–41939. https://doi.org/10.1074/jbc.M205500200
   PubMed Web of Science ®Google Scholar
• Tang, T.-C., Hu, Y., Kienlen-Campard, P., El Haylani, L., Decock, M., Van Hees, J., Fu, Z., Octave, J.-N., Constantinescu, S. N., & Smith, S. O. (2014). Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production. Structure (London, England : 1993), 22(3), 387–396. https://doi.org/10.1016/j.str.2013.12.012
   PubMed Web of Science ®Google Scholar
• Tovchigrechko, A., & Vakser, I. A. (2006). GRAMM-X public web server for protein-protein docking. Nucleic Acids Research, 34(Web Server issue), W310–W314. https://doi.org/10.1093/nar/gkl206
   PubMedGoogle Scholar
• Tsubuki, S., Takai, Y., & Saido, T. C. (2003). Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation. The Lancet, 361(9373), 1957–1958. https://doi.org/10.1016/S0140-6736(03)13555-6
   PubMed Web of Science ®Google Scholar
• Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, W., Wehnert, A., Vegter-Van der Vlis, M., & Roos, R. A. (1990). Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (New York, NY), 248(4959), 1120–1122. http://www.ncbi.nlm.nih.gov/pubmed/1971458 https://doi.org/10.1126/science.1971458
   Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M., & Rebeck, G. W. (2001). Pathogenic effects of D23N Iowa mutant amyloid β-protein. The Journal of Biological Chemistry, 276(35), 32860–32866. https://doi.org/10.1074/jbc.M104135200
   PubMed Web of Science ®Google Scholar
• Weggen, S., & Beher, D. (2012). Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer’s disease. Alzheimer's Research & Therapy, 4(2), 9. https://doi.org/10.1186/alzrt107
   PubMed Web of Science ®Google Scholar